FDA Announces Plan to Phase Out Animal Testing Requirement for mAbs and Other Drugs

📅 April 10, 2025

What the FDA announced:

Plan to phase out animal testing requirements for monoclonal antibodies and other drugs
Reinforcement of the 3R principles: Replace, Reduce, Refine animal use
Encouragement of alternative methods to animal testing to accelerate drug development & decrease costs

At PathoQuest, with our animal-free GMP NGS platform for cell bank testing and vaccine, oncolytic virus, cell/gene therapy lot release testing, we enable biopharma companies to:

Replace animal use in viral safety workflows
Speed up QC timelines and overall development
Prepare for regulatory expectations

📎 Read the FDA Announcement: CLICK HERE

👉 See our Vaccine journal publication on in vivo replacement with NGS: CLICK HERE

**Want to explore how NGS can replace in vivo testing in your viral safety strategy?**

FDA Announces Plan to Phase Out Animal Testing Requirement for mAbs and Other Drugs

What the FDA announced:​

Want to explore how NGS can replace in vivo testing in your viral safety strategy?

What the FDA announced:

**Want to explore how NGS can replace in vivo testing in your viral safety strategy?**